Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. - Wikidata - wikimedia - TriplyDB

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.

http://www.wikidata.org/entity/Q35090649

about

Mechanisms of intrahepatic triglyceride accumulation Metabolic factors and chronic hepatitis C: a complex interplay Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3 Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis.Hepatitis C virus life cycle and lipid metabolism Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation.rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.The effect of antiviral therapy on serum cholesterol levels in chronic hepatitis C Impact of hepatitis C seropositivity on the risk of coronary heart disease events.Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.A comparative study of serum lipid contents in pre and post IFN-alpha treated acute hepatitis C patients.Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.Lipid profile in cirrhotic patients and its relation to clinical outcome Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Acute hepatitis C infection lowers serum lipid levels Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection Association between phase angle, anthropometric measurements, and lipid profile in HCV-infected patients.MTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients.Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional study.Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b.Cholesterol and chronic hepatitis C virus infection.Current understanding of insulin resistance in hepatitis C.Lipids and HCV.Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.Is genotype 3 of the hepatitis C virus the new villain?Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.

P2860

Q26773198-15E863B8-B238-4B11-88AD-890E3408ED5F Q27011787-067F181D-7E1D-4910-BCE7-DEC9AF258EAE Q28484313-3D26AF8F-2276-4A64-A9A3-32AC353AD392 Q28539645-70D46A20-9079-4B09-B6E2-544C370201F4 Q28543090-313165B7-F301-4509-9E3E-8053C521CF3E Q33803319-968B2066-DC0F-4AE6-87F7-33C11E4A3A69 Q34046758-D32F40FE-B291-4CE9-8ABC-1CA024DDC982 Q34734158-C8EBD3FD-3D83-4BED-9CEA-CD4928B19225 Q34792436-0A1BA217-1A07-4F0B-B63E-4FE5ECD2BC6D Q34993666-CF744D09-3392-4D8A-925C-1EF1287E3289 Q35072020-57DF11E4-210A-43D5-9B6E-99E57F8F8B27 Q35122536-AE934DC9-DB95-47A1-A90E-B02B75708124 Q35128041-E2BB1F68-3DF4-4798-882B-DA0DD4FBC619 Q35142495-A1820F32-89F6-4B9A-B923-A74664CDC6BF Q35195470-C4014A5A-F81E-4FB9-A24C-193FB7A0A661 Q35214000-8E7CE51B-CAA7-4163-BC06-8C70C68B6059 Q35838417-9C32D938-FF09-483A-BFBA-4CDC64F71FCC Q35861534-44D26106-911C-489E-B54F-533DD1199733 Q36032672-FD42C3FC-6C10-48E6-A4BB-44DF8FEC149E Q36092768-0B94AE38-C2E0-44F4-B52A-70648EB6ED4F Q36146807-E26BAA83-7316-4808-970A-9FED6E3CA7C0 Q36364602-E52AED51-8C63-43AC-938B-FF77D146E0DA Q36379566-16995618-C853-4465-A232-CE54677F52F9 Q36457831-1954805C-0BA3-4A83-A1CC-F7022705D6C0 Q36497046-8E36CB05-089C-410F-BF34-88FD022C0186 Q36533249-6873DECC-1608-441A-AF8C-6F5DE5A9BA64 Q36760026-3B9676DA-1294-4855-AD50-0A07E208425F Q37015738-4A692B58-110B-4F6A-AF89-725679A7DDBE Q37084874-81E45924-CC0A-447E-B2BB-D36CDE27A96D Q37151984-F39FCCF9-76D0-49D9-AFD5-35FA1B69D2CC Q37342497-ABC59BA3-6B24-419E-8BB9-C1EF8995C942 Q37370730-89EF4C6E-6428-4B9D-9AE5-84FE94869BC4 Q37525930-E606668D-492E-4B87-A4C7-C7BA2E87D668 Q37743001-39C8A6C5-3D95-4B72-BD66-C0DFA98A24EB Q37891171-32CA37AE-1235-4510-838C-5466419386D9 Q37903853-0DA37C0E-F2E9-41CC-A5B1-87F430503F57 Q38056643-760E8594-8C1A-496E-A2C4-B01EC59FB147 Q38134774-176633B4-BF0C-4515-9498-B1838926959A Q38155123-B476C886-E494-499E-B5EF-5097182676EA Q38217418-7D35F942-EBCA-4BA2-9C79-0876047AE60B

P2860

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.

http://www.wikidata.org/entity/Q35090649

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatitis C virus infection an ...... tions for long-term follow-up.

@ast

Hepatitis C virus infection an ...... tions for long-term follow-up.

@en

type

label

Hepatitis C virus infection an ...... tions for long-term follow-up.

@ast

Hepatitis C virus infection an ...... tions for long-term follow-up.

@en

prefLabel

Hepatitis C virus infection an ...... tions for long-term follow-up.

@ast

Hepatitis C virus infection an ...... tions for long-term follow-up.

@en

P1433

Q35090649-3EFFFA97-3333-4A84-AF5D-28D1E8CB9C12

P1476

Q35090649-6EF13BCC-3505-47FB-BFC8-122C9E3E86AB

P2093

Q35090649-4C3FA884-E26D-4F34-A847-85ADCAE5B092

Q35090649-7BDE92C9-5377-4D28-BC60-90B49E0BB838

Q35090649-92E6490D-1656-4998-BB66-A188340A9293

Q35090649-A22E37BF-8711-442C-84D8-6CCD256AE4A0

Q35090649-A63FF61B-F30F-4020-A9B6-C70BFA4A4B5D

P2860

Q35090649-28052A9B-6F63-4AA5-A655-477F3C64416F

Q35090649-29BA4156-297B-472B-BADA-3CD2D64F891D

Q35090649-2D1C4135-F908-4FCD-9B8D-7F734CC68116

Q35090649-331EC6A7-4CF6-43A0-B796-0F34139EB162

Q35090649-3FC15657-BBD4-4792-969A-465CD8F9BF7D

Q35090649-4642E383-0A25-4195-B2B5-64112DE30738

Q35090649-5CAFFA84-5BD6-41B0-A9CC-A686AB3CE16B

Q35090649-66C4DA32-31F9-4FD3-A1D8-42FE2AEA55BA

Q35090649-66CACE71-4D0E-4207-A97F-CC14910B3B42

Q35090649-6E3D3D25-E5F5-4D0C-B816-3D0F9E47FB8E

P304

Q35090649-C24FB103-EBFA-45E0-A7AE-A8FF489E5EAF

P31

Q35090649-9DEA2EE5-4D58-4185-B21D-11C80C034217

P356

Q35090649-D66FCBA3-84F6-48F2-B8B3-20F7349FC76A

P407

Q35090649-B0829918-64EA-42C7-9AD4-E04295A42892

P433

Q35090649-012949BD-6DC6-497F-9F40-A728537246C0

P478

Q35090649-B180EEC7-02F7-462E-A004-A74506AF09D9

P50

Q35090649-5F44F6F8-968E-48D8-8D78-5EE3918B4C3D

P577

Q35090649-C02DBCEF-0594-4C47-8296-40219820247E

P5875

Q35090649-CA613101-AAB2-4E58-8A17-8C2C960180FE

P698

Q35090649-CDD87D74-2C98-4DB9-86F7-A9A6099C6F82

P932

Q35090649-F61E7292-BFAD-45AF-8742-5191564E1B48

P356

P1433

P1476

Hepatitis C virus infection an ...... tions for long-term follow-up.

@en

P2093

Craig Munroe

http://www.w3.org/2001/XMLSchema#string

Erin Kane

http://www.w3.org/2001/XMLSchema#string

Hui Zheng

http://www.w3.org/2001/XMLSchema#string

Kathleen E Corey

http://www.w3.org/2001/XMLSchema#string

Lydia L Barlow

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

A receptor-mediated pathway for cholesterol homeostasis

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Interaction of hepatitis C virus proteins with host cell membranes and lipids.

P304

1030-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23219

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Raymond T Chung

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26854679

http://www.w3.org/2001/XMLSchema#string

P698

19787818

http://www.w3.org/2001/XMLSchema#string

P932

4330996

http://www.w3.org/2001/XMLSchema#string